DR. ALASNAG was the first female interventional cardiologist in the Gulf region and
represents women on multiple committees.
Dr Albin is a neurointensivist at Emory University. She is a passionate clinician educator and serves on the Editorial Board of Neurocritical Care Society’s ONCALL and the Digital Strategy Team for Stroke: Vascular and Interventional Neurology. She is a co-editor of the Acute Neurology Survival Guide and a frequent contributor to free, open access medical education blogs and podcasts.
Dr. Ambruso is a clinical nephrologist and assistant professor at the Rocky Mountain VA Medical Center, Renal Division and University of Colorado School of Medicine; Division of Renal Disease and Hypertension.
Alessia Argirò is a cardiologist and PhD student actually working in the Referral Center for Cardiomyopathies in Florence (Italy).
Christos Argyropoulos is Associate Professor of Nephrology and Section Chief of the Division of Nephrology at the University of New Mexico School of Medicine.
Geoff Barnes is a cardiologist and vascular medicine specialist at the University of Michigan Health System. He completed his undergraduate degree in biomedical engineering at Washington University in St. Louis (2003) followed by medical school at the University of Michigan (2007).
Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS-AQ Cardiology, CACP graduated in 2009 from the University of Kentucky (UK) College of Pharmacy and completed a PGY1 pharmacy practice residency and a PGY2 cardiology pharmacy residency at UK Albert B. Chandler Hospital in Lexington, Kentucky (R365). Dr. Beavers is an assistant adjunct professor with the University of Kentucky College of Pharmacy.
Dr. Joshua Beckman is a Professor of Medicine at Vanderbilt Medical School,
Director of the Section of Vascular Medicine, and Director of the Cardiovascular
Consultation Service at Vanderbilt University Medical Center. After earning his
MD from New York University School of Medicine, he completed medical
residency in internal medicine at Columbia Presbyterian Medical Center and
postgraduate fellowships in cardiovascular medicine and vascular medicine at
Brigham and Women's Hospital.
Sheila Bermejo is a clinical nephrologist who is currently working at Vall d’Hebron Hospital in Barcelona, Spain. Her expertise focuses in diabetic kidney disease, onconephrology and glomerular disease.
Deepak L. Bhatt MD, MPH, FACC, FAHA, MSCAI, FESC, is Director of Mount Sinai Heart and the Dr. Valentin Fuster Professor of Cardiovascular Medicine at the Icahn School of Medicine at Mount Sinai Health System. After graduating as valedictorian from Boston Latin School, Dr. Bhatt obtained his science degree as a National Merit Scholar at MIT. He received his MD from Cornell and MPH from Harvard. He is working on his Executive MBA from Oxford. He trained in internal medicine at the University of Pennsylvania and in cardiology at Cleveland Clinic.
Snehal H. Bhatt is Professor of Pharmacy Practice at the MCPHS University, and Clinical Pharmacist at the Beth Israel Deaconess Medical Center, in Boston, MA. He teaches and practices in acute care cardiology, anticoagulation, clinical pharmacokinetics, and adult internal medicine. Dr. Bhatt is a Board Certified Pharmacotherapy Specialist (BCPS) with Added Qualifications in Cardiology. His scholarly interests include inpatient anticoagulation for the prevention and treatment of thrombosis, anticoagulation reversal therapies, and the role of the pharmacists in the management of cardiovascular disease.
Dr. Blood is an Instructor of Medicine at Harvard Medical School and clinical and implementation science researcher at Brigham and Women’s Hospital in Boston, Massachusetts. Through the Accelerator of Clinical Transformation group at Brigham and Women’s Hospital, he acts as the Director of Medical Operations and Innovation.
Marc P. Bonaca, MD, MPH, FAHA, FACC is a cardiologist and vascular medicine specialist who serves as the executive director of CPC Clinical Research and Community Health, as well as Director of Vascular Research and Professor of Medicine at the University of Colorado Anschutz Medical Campus.
Allison received her pharmacy doctorate from the University of New Mexico College of Pharmacy in 2003, then completed a general pharmacy practice residency at Boston Medical Center in 2004. She now serves as lead pharmacist of the Inpatient Antithrombosis Stewardship program at the University of New Mexico Health Sciences Center and as an associate adjunct clinical professor at the UNM College of Pharmacy.
John Camm is British Heart Foundation Professor of Clinical Cardiology (emeritus) at St George’s University of London, London, UK. His interests include cardiac arrhythmias, atrial fibrillation, stroke prevention, and anticoagulation.
Dr. Cannon is a Professor of Medicine at Harvard Medical School, and senior physician in the Cardiovascular Division at Brigham and Women’s Hospital. He currently serves as Education Director in the Cardiovascular Innovation group. He has worked for 25 years as an investigator in the TIMI Study Group, then for 5 years with the Harvard Clinical Research Institute (now Baim Institute).
Dr. Marc Carrier, M.D., MSc, FRCPC, is Head of the Division of Hematology at The Ottawa Hospital, a Professor in the Faculty of Medicine, Department of Medicine and Senior Scientist in the Clinical Epidemiology Program of The Ottawa Hospital Research Institute. He holds a Tier 1 Research Chair in Venous Thromboembolism and Cancer from the Faculty of Medicine at the University of Ottawa.
Clara García Carro is a clinical nephrologist currently working at Nephrology Department of Hospital Clínico San Carlos in Madrid (Spain).
As a nephrologist, and since she started her internship in Nephrology at Hospitall Vall d’Hebron, Barcelona (Spain), she has been always working in a tertiary hospital environment, being in charge of the outpatients clinic and hospitalization. She has been working in Clinical Nephrology but she also has experience as a transplant nephrologist since her career has been developed in hospitals with huge transplantation rates.
Brooks D. Cash, MD is Chief of the Division of Gastroenterology, Hepatology, and Nutrition at the University of Texas Health Science Center at Houston, where he is also the Dan and Lillie Sterling Professor of Clinical Gastroenterology at the University of Texas McGovern Medical School and the Endowed Director of the Chao-Ertan Directorship at Memorial Hermann Hospital Texas Medical Center. Dr. Cash has authored over 200 articles and book chapters on a wide variety of gastrointestinal topics.
Dr. Cheng is an Endocrinologist at Trillium Health Partners and Unity Health Toronto and an Associate Professor at the University of Toronto. She has been involved with the development of the Diabetes Canada clinical practice guidelines since 2003 and served as Chair for the 2013 version. Currently, she is the Chair of the Professional Section of Diabetes Canada and an Associate Editor for the Canadian Journal of Diabetes.
Dr. Choi is a neurointensivist and the Medical Director of the ChristianaCare Neurocritical Care Unit and the Transitional Neurological Unit in Newark, DE and is a Clinical Assistant Professor of Neurology for the Sidney Kimmel Medical School at Thomas Jefferson University in Philadelphia, PA. He is passionate about FOAMed in addition to Ethics in Neurocritical Care, and care of ICH and TBI patients.
Mauricio G. Cohen, MD, FACC, FSCAI is a Professor of Medicine at the University of Miami Miller School of Medicine .
Jean M. Connors, MD is a hematology attending at Brigham and Women’s Hospital and Dana Farber Cancer Institute; the Medical Director of the Anticoagulation Management Services, and the Hemostatic Antithrombotic Stewardship Program; and an Associate Professor of Medicine at Harvard Medical School.
Ricardo Correa is the Associate Professor, Program Director for Endocrinology, diabetes and metabolism fellowship and the Director for Diversity on GME for the University of Arizona College of Medicine-Phoenix. He serves as staff clinician and researcher at Phoenix VAMC. Additionally, he is faculty for The Mayo SOM-Arizona and for Creighton SOM-Phoenix Campus. He is an editor of Dynamed, Empower magazine, and outreach unit director of Endotext.org and Thyroid manager.
Dr. Dave Dixon is the Nancy L. and Ronald H. McFarlane Professor of Pharmacy and
Chair of the Department of Pharmacotherapy & Outcomes Science at Virginia
Commonwealth University School of Pharmacy. He is also a clinical pharmacy specialist
at VCU Health and affiliate faculty of the VCU Pauley Heart Center.
Dr. Dobesh is responsible for teaching pharmacy and medical students as well as pharmacy and medical residents and lectures in the area of ischemic heart disease, antithrombotic therapy, and other cardiology and critical care topics. Dr. Dobesh has conducted research on antiplatelet and antithrombotic therapy, focusing on real-world utilization and health-economics. He has also published book chapters and several manuscripts in this area.
Professor Thor Edvardsen is Head, Dept. of Cardiology at Oslo University Hospital in Norway and a professor at the Institute of Clinical Medicine at the University of Oslo. Edvardsen is elected as the EACVI President 2018-20 and has been an elected Board member in EACVI since 2010.
John Fanikos, R.Ph., MBA, is Chief of Pharmacy Services at Brigham and Women's Hospital (BWH) in Boston, Massachusetts. He is responsible for the overall Pharmacy Department operations and its financial performance. Mr. Fanikos also serves as Adjunct Professor of Clinical Pharmacy at Massachusetts College of Pharmacy and Health Sciences (MCP). He earned his Bachelor of Science degree in Pharmacy at Massachusetts College of Pharmacy and his Master of Business Administration degree at Northeastern University. He completed an ASHP-accredited residency at BWH.
Gregory J. Fermann, MD, FACEP, FHFSA serves as Professor and Executive Vice Chair of Emergency Medicine at the University of Cincinnati College of Medicine. He also serves as the Vice Chair of Research and the Director of the Clinical Trials Center in the Department of Emergency Medicine. Dr. Fermann is an internationally recognized thought leader and researcher in acute cardiovascular emergencies, specifically acute coronary syndrome, heart failure, thrombosis, arrhythmias, and major hemorrhage related to anticoagulant use. He completed his undergraduate degree in chemistry at Saint Louis University, his medical degree at the University of Cincinnati and his training in emergency medicine at the Maricopa Medical Center integrated program in Phoenix, Arizona.
Kevin is a part-time GP Partner working at North Berwick Health Centre, near Edinburgh. Kevin is also Scottish lead of the Primary Care Diabetes Society, Content Advisor for WebMD Medscape Global & UK and a co-founder of GoggleDocs.
C. Michael Gibson, M.S., M.D. is an interventional cardiologist, cardiovascular researcher & educator. He is the CEO of the combined non-profit Baim and PERFUSE research institutes at Harvard Medical School. The institutes have led over 1,000 studies, published 3,000 manuscripts in the peer review literature, and have led 60 FDA submissions from their network of 7,000 sites worldwide. In 2014, 2018 and 2019 Gibson was ranked as one of the world's most highly cited authors in all of science in the past decade by Thomson Reuters. His work has been cited over 107,000 times, and he has an H index of 118 and an i10- index of 469.
Dr. Shaun Goodman is a Staff Cardiologist and Associate Head in the Division of Cardiology, Department of Medicine, at St. Michael’s Hospital. He is a Professor and Heart & Stroke Foundation of Ontario (Polo) Chair in the Department of Medicine at the University of Toronto.
Dr. Ilana Halperin is a full time staff physician and assistant professor in the job description of Clinician in Quality and Innovation. Dr. Halperin has a BSc from McGill University, an MD from the University of Western Ontario; she completed internal medicine and endocrinology training at the University of Toronto and an MSc in Quality Improvement and Patient Safety at the Institute for Health Policy, Management and Evaluation, University of Toronto.
Will Herrington is a clinician scientist based at the Nuffield Department of Population Health, University of Oxford and a practising Honorary Consultant Nephrologist at Oxford Kidney Unit. He joined the Renal Studies Group as a Clinical Research Fellow and trained on landmark renal trials (SHARP, 3C and UKHARP3). In 2013, he was awarded an MD from the University of Cambridge for a thesis entitled ‘The effects of lowering LDL cholesterol on stroke in chronic kidney disease’.
Mellanie True Hills is a heart disease survivor, heart health expert, patient advocate, award-winning author, and founder and CEO of the non-profit American Foundation for Women's Health and StopAfib.org, the world's foremost atrial fibrillation patient advocacy organization. As she shares her inspiring personal story of her brush with death in emergency heart surgery, and subsequent close call with a stroke due to an irregular heartbeat, atrial fibrillation, she helps audiences take control of their own lives.
Dr. Holmes has been a GP Partner at St. George’s Medical Practice, Darlington for 23 years. He is a local clinical commissioner for diabetes (Diabetes Clinical lead for Tees Valley CCG & Primary Care Diabetes Clinical Lead for the North-East ICS).
Diana Isaacs, PharmD, BCPS, BC-ADM, BCACP, CDCES, FADCES, FCCP is an Endocrinology Clinical Pharmacy Specialist and the Continuous Glucose Monitoring Program Coordinator at the Cleveland Clinic Endocrinology and Metabolism Institute. Dr. Isaacs earned her bachelor’s degree in Chemistry from the University of Illinois at Chicago, Doctor of Pharmacy Degree from Southern Illinois University Edwardsville (SIUE) and completed a pharmacy practice residency at the Philadelphia VA.
Noah Ivers is a family physician at Women's College Hospital, scientist at Women’s College Research Institute, and innovation fellow at the Women's College Institute for Health System Solutions.
Dr. Jackevicius is a Professor and Director of the Cardiovascular Outcomes Research Fellowship in the College of Pharmacy at Western University of Health Sciences, an Associate Professor in the Institute for Health Policy, Management and Evaluation at the University of Toronto, a Senior Adjunct Scientist at ICES in Toronto, and a Cardiology Clinical Pharmacist Practitioner at the VA GLA Healthcare System, where she is the Associate Director of the Cardiac Risk Reduction Clinic and the Heart Failure Consultation Clinic.
I am a clinical cardiologist and work as associate professor of Internal Medicine at Rio de Janeiro State University, where I coordinate the discipline of Clinical and Experimental Pathophysiology as well as our cardiometabolic unit. During my entire career I have been involved in continued medical education in my country, as well as abroad. I have always advocated for preventive cardiology, and my main interests in this field are obesity, Type 2 diabetes primary and secondary prevention of atherosclerotic heart disease. In addition, I also have a strong interest in heart failure.
Dr. Ko is a cardiologist and a researcher. She is dedicated to generating evidence for and implementation of safe and effective novel cardiovascular therapies in medically complex older adults. She received her medical degree at Columbia University Vagelos College of Physicians & Surgeons and completed Internal Medicine Residency and Cardiovascular Medicine Fellowship at Boston Medical Center.
Dr. Mikhail Kosiborod is a cardiologist, the Vice President of Research at Saint Luke’s Health System, Executive Director of the Cardiometabolic Center Alliance, Director of Cardiometabolic Research and Co-Director of the Haverty Cardiometabolic Center of Excellence at Saint Luke’s Mid America Heart Institute, and Professor of Medicine at the University of Missouri-Kansas City. Dr. Kosiborod received training in clinical research, epidemiology and health policy through the Robert Wood Johnson Clinical Scholars Program, as well as clinical training in cardiovascular medicine at Yale University School of Medicine.
Edgar Lerma, MD, earned his Doctor of Medicine from the University of Santo Tomas Faculty of Medicine and Surgery in Manila, Philippines. He completed Residency Training in Internal Medicine at UIC/Mercy Hospital and Medical Center, where he also served as Chief Resident. He completed a Fellowship in Nephrology and Hypertension at Northwestern Memorial Hospital, the Feinberg School of Medicine at Northwestern University, and the Veterans Administration Lakeside Medical Center in Chicago, Illinois.
Jerrold Levy is Professor of Anesthesiology, Critical Care, Surgery (Cardiothoracic) at Duke University Medical Center in Durham, NC. He obtained his medical degree from the University of Miami, where he was an intern in internal medicine, and undertook his residency in the Department of Anesthesiology of the Massachusetts General Hospital and Harvard Medical School in Boston, where he was also Chief Resident, and completed fellowships in both Respiratory ICU and Cardiac Anesthesiology. He previously was Professor, Deputy Chair for Research, and Chief of Cardiothoracic Anesthesiology at Emory University.
Jane Linderbaum is an Associate Professor of Medicine at Mayo Clinic in Rochester, Minnesota, and the Associate Medical Editor for AskMayoExpert (AME), a point-of-care, content-delivery tool that aids Mayo Clinic providers in making the right clinical decision, for the right patient, at the right time. Jane leads teams of expert collaboration and consensus-driven creation of Care Process Models (CPMs), and point-of care decision tools for busy clinicians. Jane maintains an active practice in Cardiovascular Medicine, structural heart disease, with focus on hypertrophic cardiomyopathy and valvular heart disease.
Dr. Marcolini earned her medical degree from University of Vermont College of Medicine, completed residency in Emergency Medicine at Maine Medical Center and fellowship in Surgical Critical Care at R Adams Cowley Shock Trauma Center. She is board certified in Emergency Medicine (ABMS) and Neurocritical Care (UCNS). She served as faculty at R Adams Cowley Shock Trauma Center and University of Maryland in Surgical Critical Care and Emergency Medicine, followed by faculty appointment in Emergency Medicine and Neurology at Yale, where she worked in Emergency Medicine, Surgical Critical Care and Neurocritical Care. She is now faculty at Geisel School of Medicine at Dartmouth in Emergency Medicine and Neurology and practices Emergency Medicine and Neurocritical Care.
Dr. Martin is the Section Chief of Surgical Critical Care, Program Director for the Traumatology & Surgical Critical Care Fellowship, Vice Chair for Diversity & Inclusion, and an Associate Professor of Surgery at the University of Pennsylvania. He is also the Medical Director of the Trauma & Surgical Intensive Care Unit at the Penn Presbyterian Medical Center. Dr. Martin is a board-certified Diplomat of the American Board of Surgery for both Surgery and Surgical Critical Care, a Fellow of the American College of Surgeons, and a Fellow of the American College of Critical Care Medicine.
Previously, Dr. Mayer was Director of Neurocritical Care and Professor of Neurology and Neurological Surgery at Columbia University College of Physicians and Surgeons in New York.
Ahmad Masri is the Director of the Hypertrophic Cardiomyopathy Center and Cardiac Amyloidosis Program at Oregon Health & Science University where he is also an Assistant Professor of Medicine. Dr. Masri obtained his medical degree from Jordan University of Science and Technology in Jordan prior to joining the Cleveland Clinic where he completed his Internal Medicine Residency training, followed by Cardiology fellowship, NIH-sponsored T32 imaging fellowship in cardiac imaging, and a post-graduate degree in Epidemiology and Statistics from the University of Pittsburgh.
Dr. Mehran is Mount Sinai Professor in Cardiovascular Clinical Research and Outcomes as well as Professor of Medicine (cardiology) and Population Health Science and Policy at the Icahn School of Medicine at Mount Sinai, and is an internationally renowned interventional cardiologist and clinical research expert in the field of cardiovascular disease. A prolific researcher, she has served as principal investigator for numerous global studies, developed risk scores for bleeding and acute kidney injury, participates regularly in developing clinical guidelines, and has authored more than 900 peer-reviewed articles. She has been included in Clarivate Analytics: The most influential scientific minds as one of the highly cited researchers for several consecutive years.
Dr. Erin Michos is an Associate Professor in the Division of Cardiology at Johns Hopkins School of Medicine, with joint appointment in Epidemiology at Johns Hopkins Bloomberg School of Public Health.
Consultant Cardiologist Lecturer of Cardiology-Cairo University. Author of "Tips and Tricks in Cardiology" book. Ambassador for Africa in the Tele-Cardiology Working Group-International Society for Telemedicine &eHealth (ISfTeH).
Dr. Morris is a neuro-intensivist and Associate Professor in the Department of Neurology and the Program in Trauma at the University of Maryland School of Medicine where he serves as Program Director for the fellowship in neurocritical care, the Chair of the University of Maryland Medical Center Resuscitation Committee, and the Associate Director of the Shock Trauma Simulation Center.
Rohit Moudgil, MD, PhD, is a cardiologist in the Section of Clinical Cardiology, Tomsich Family Department of Cardiovascular Medicine, Sydell and Arnold Miller Family Heart, Vascular & Thoracic Institute. His primary interest is in cardio-oncology. The cardio-oncology field emerged to ensure comprehensive medical care for cancer patients, with an emphasis on risk stratification, complication prevention, and cardiovascular health optimization, which may collectively dictate eligibility for and response to various cancer therapies, and thus, improve overall outcome and survival.
Prof. Denisa Muraru is a cardiologist specialized in Imaging-Echocardiography at Istituto Auxologico Italiano, IRCCS, San Luca Hospital (Milan) and Assoc. Professor at University of Milano-Bicocca. She graduated from University of Medicine in Bucharest (Romania) and received the PhD degree in 2013 from University of Padua (Italy).
James Novak, MD PhD FASN FNKF FACP is the Nephrology and Nephrology/Critical Care Training Program Director at Henry Ford Hospital in Detroit, Michigan; Professor of Clinical Medicine at Michigan State University; and Education Director for the American Society of Nephrology Kidney Self-Assessment Program (KSAP). He has received the Subspecialty Teaching Physician of the Year Award from the Internal Medicine house staff for 7 years as well as medical student teaching awards from Henry Ford Hospital and Wayne State University.
Dr. Katelyn O'Brien is a clinical pharmacy specialist at Boston Medical Center - the largest health safety net hospital in New England. She graduated from the University of Connecticut School of Pharmacy in 2014 and went on to complete her PGY1 Pharmacy Residency at VA Boston Health Care System.
Prof. Iacopo Olivotto is Head of the Cardiology Unit at Meyer University Children Hospital and Professor of Cardiovascular Medicine at the University of Florence, Italy. Over the last two decades, his main clinical and research interests have included various aspects of cardiomyopathies, with special focus on hypertrophic cardiomyopathy.
Siddharth Patel, MD, MPH, is currently a senior fellow in cardiovascular medicine and critical care at Brigham and Women's Hospital and a research fellow with the TIMI Study Group. He received his medical degree from UT Southwestern medical school, an MPH from the Harvard T.H. Chan School of Public Health, and clinical training in Internal Medicine, Cardiovascular Medicine and Critical Care at Brigham and Women’s Hospital and Harvard Medical School.
Professor Fausto Pinto received his MD and PhD from the Lisbon University Medical School and completed fellowships at Santa Maria University Hospital (Lisbon, Portugal), and Stanford University Medical School (CA, USA), where he was also Clinical Attending in the Echocardiography laboratory. He is Full Professor of Cardiology/Medicine alongside serving as the Head of the Cardiovascular Department of Santa Maria University Hospital and President of the Cardiovascular Center of University of Lisbon (CCUL). He was the Dean of the Faculty of Medicine of the University of Lisbon (2015-22) as well as National Coordinator of the Medical Schools Council (2018-2020), President of the Executive Board of the Lisbon Academic Medical Centre (2019-21).
Dr. Charles Pollack is a Clinician-Scientist in the Department of Emergency Medicine at the University of Mississippi School of Medicine. He has long been active in teaching and clinical research and is an international leader in emergency medicine. He is the only physician to have received the American College of Emergency Physicians’ highest national awards in both teaching and research; he also received the national teaching award from the Council of Emergency Medicine Residency Directors.
Dr. Richard Pratley serves as Samuel E. Crockett Chair in Diabetes Research, Senior Investigator and Diabetes Program Lead at the AdventHealth Translational Research Institute, and Medical Director at the AdventHealth Diabetes Institute, in Orlando, Florida. He is also an Adjunct Professor of Medicine with the Johns Hopkins University School of Medicine. Dr. Pratley is an internationally recognized expert in diabetes and is board certified in internal medicine.
Amar Puttanna is a Diabetes and Endocrine Consultant in the West Midlands, UK and a founding member of ‘Goggledocs’ – a well-known medical education team from the UK.
Dr. Pyslar is a Founder and Director of Lipid Disorders Clinic and Cardiovascular Genetics at Cook County Health in Chicago, IL. She is a Faculty Attending Cardiologist and Board Certified Lipid Specialist with primary expertise in Lipid Metabolism Disorders, Atherosclerosis and Preventive Cardiology, providing care to the underserved communities of Cook County, IL.
Dr. Rajagopal is an Associate Professor of Medicine with a secondary appointment in Biochemistry at the Duke University School of Medicine.
Dr. Rao is Professor of Medicine at Duke University Medical Center, and the Section Chief of Cardiology at the Durham VA Medical Center. At the national level, Dr. Rao serves as the Editor-in-Chief for Circulation Cardiovascular Interventions, the interventional journal of the American Heart Association’s flagship Circulation family of journals.
Brian Rifkin, MD, is a board-certified general and interventional nephrologist at the Hattiesburg Clinic in Hattiesburg, MS.
Professor of Medicine University of Pittsburgh Medical Center, Heart and Vascular Institute, Pittsburgh, PA, USA University of Baskent, Ankara, Turkey Vice-President, Chair Echo Section, EACVI Past President Working Group on Cardiac Imaging, Turkish Society of Cardiology.
Naveed Sattar is Professor of Metabolic Medicine, University of Glasgow. He is interested in the prevention, causes and management of obesity, diabetes and cardiovascular outcomes.
Dr. Schaff is the Stuart W. Harrington Professor of Surgery and a consultant in the Division of Cardiovascular Surgery at Mayo Clinic, Rochester, Minnesota. He received his medical degree from the University Of Oklahoma School of Medicine and trained in general and thoracic surgery at Johns Hopkins Hospital.
Doctor of Medicine (Cum Laude) from the University of Granada. Diego Segura-Rodríguez is a cardiologist specialized in heart failure, pulmonary hypertension and multimodality cardiac imaging. His main areas of clinical and research interest include heart failure, cardio-renal metabolism, pulmonary hypertension, echocardiography, cardiac magnetic resonance, atrial fibrillation and preventive cardiology. He is member of the Editorial Board of the European Heart Journal of Cardiovascular Imaging and Social Media editor. He has an extensive teaching activity in cardiovascular medicine, being involved in frequent lectures, seminars and scientific forums.
Dr. Shah is the Stone Endowed Professor of Medicine and Director of Research for the Bluhm Cardiovascular Institute at Northwestern University Feinberg School of Medicine. Dr. Shah is also Director of the Center for Deep Phenotyping and Precision Therapeutics in the Institute or Augmented Intelligence in Medicine at Northwestern University, and he is Director of the Heart Failure with Preserved Ejection Fraction (HFpEF) Program at Northwestern Memorial Hospital in Chicago, Illinois, USA.
Dr. Shoamanesh is an Associate Professor of Medicine (Neurology) at McMaster University, where he holds the Marta and Owen Boris Chair in Stroke Research and Care, and the founding Director of the Hemorrhagic Stroke Research Program and a Scientist at the affiliated Population Health Research Institute.
Natalie Staplin is a senior statistician based at the Nuffield Department of Population Health, University of Oxford.
Dr Steg received the silver medal of the European Society of Cardiology in 2011, the Joseph A Vita Award from the American Heart Association in 2019 and the Grand Prix Claude Bernard de la Ville de Paris in 2019.
Dr. Deborah Siegal MD MSc FRCPC is an Associate Professor of Medicine at the University of Ottawa and Associate Scientist at the Ottawa Hospital Research Institute. She holds a Tier 2 Canada Research Chair in Anticoagulant Treatment of Cardiovascular Disease. She received MSc degrees in Pharmacology and Health Research Methodology.
Dr. Brett W. Sperry is a cardiologist at Saint Luke's Mid America Heart Institute with a subspecialty in Advanced Heart Failure, Transplantation, and Mechanical Circulatory Support. He is an Associate Professor of Medicine at the University of Missouri-Kansas City. Dr. Sperry completed medical school and Internal Medicine residency at Georgetown University in Washington, DC. He completed fellowship training in both Cardiovascular Medicine and Advanced Heart Failure and Transplantation at the Cleveland Clinic in Cleveland, Ohio.
Alex C. Spyropoulos, MD received his medical degree from the Perelman School of Medicine at the University of Pennsylvania in Philadelphia, PA. He completed his internship and residency in internal medicine at the University of New Mexico Health Sciences Center in Albuquerque, NM. He is board certified in Internal Medicine. Dr. Spyropoulos was Founder and former Medical Director of the Clinical Thrombosis Center in Albuquerque, New Mexico. He is a Professor of Medicine at the Zucker School of Medicine at Hofstra/Northwell and System Director of Anticoagulation and Clinical Thrombosis Services for the multi hospital Northwell Health System in NY.
Carlo Trinidad is a clinical nephrologist and head of the Division of Nephrology as well as the Renal Care Center of the Dagupan Doctors Villaflor Memorial Hospital in Pangasinan province, the Philippines.
Dr. Underberg is a Clinical Assistant Professor of Medicine in the Division of General Internal Medicine at NYU Medical School and is a member of the executive committee of the Division of General Internal Medicine . His clinical focus is Preventive Cardiovascular Medicine. He is an American Society of Hypertension Certified Specialist in Clinical Hypertension , a Diplomate of the American Board of Clinical Lipidology, and a North American Menopause Society Certified Menopause Practitioner.
Muthiah Vaduganathan, MD MPH FACC is a cardiologist at Brigham and Women’s Hospital and Harvard Medical School (Boston, MA). His research focuses on drug development, clinical trials, and implementation of cardio-renal-metabolic therapies. He has authored or co-authored more than 400 peer-reviewed publications. Dr. Vaduganathan serves on the editorial boards of the European Journal of Heart Failure, JACC Heart Failure (Social Media / CME Editor), & JACC (FIT / Early Career Section Editor). He participates as an investigator and Clinical Endpoints Committee member for ongoing advanced-phase trials in HF and cardiometabolic medicine.
Frederik H. Verbrugge is a Cardiologist/Intensive Care physician with dedicated interest in heart failure, (exercise) hemodynamics & cardiorenal physiology. Prof. Dr. Verbrugge graduated as M.D. in 2010 (KU Leuven, Belgium), obtained his Ph.D. in 2015 (Hasselt University, Belgium) & received an M.Sc. in Clinical Trials in 2022 (Oxford University, UK).
Tzu-Fei Wang, MD, MPH is a hematologist and an associate professor in the Division of Hematology, Department of Medicine at the University of Ottawa and the Ottawa Hospital and an associate scientist at the Ottawa Hospital Research Institute. Her main areas of clinical and research interest include clinical research for the optimal prevention and treatment strategies for patients with cancer-associated thrombosis, drug-drug interactions with anticoagulants, and obesity-related thromboembolism.
Patricia Wedge, RN, BSN, CCRC is a heart failure nurse by training. She has worked in the cardiovascular nursing space from 1996 to June 2022 at Tufts Medical Center in Boston, MA. She also has 25+ years experience working in cardiovascular clinical trials. She started out a study coordinator working on lipid trials at Tufts Medical Center in Boston, moved into the cardiovascular clinical research organization space, managing the clinical operations of the organization as the Vice President. More recently she has joined Baim Institute for Clinical Research as the Executive Vice President of Clinical Trial Services where she oversees the organizations clinical trial operations including project management, clinical operations, data management, safety, CEC, DSMB, biostatistics, imaging core laboratory and legal services.
Susan Weiner, MS, RDN, CDCES, FADCES is a registered dietitian/nutritionist and certified diabetes care and education specialist and the owner and clinical director of Susan Weiner Nutrition, PLLC. She served as a director for the Association of Diabetes Care and Education Specialists (ADCES) board of directors and is an ADCES Fellow. Ms. Weiner served as conference chair for ADCES22 and was appointed to the Credentialing Taskforce for ADCES and the Certification Board of Diabetes Care and Education Specialists to examine and explore future credentialing for the interdisciplinary profession.
Dr. Weitz is Professor of Medicine and Biochemistry and Biomedical Sciences at McMaster University and Executive Director of the Thrombosis and Atherosclerosis Research Institute. Board Certified in Internal Medicine, Hematology and Medical Oncology, Dr. Weitz focuses his clinical practice on patients with thrombotic disorders. His research spans the spectrum from basic studies in the biochemistry of blood coagulation and fibrinolysis to animal models of thrombosis and on to clinical trials of antithrombotic therapy.
Dr. Ronald Witteles is a cardiologist who specializes in the treatment of patients with Heart Failure. He has particular expertise in the treatment of Amyloidosis, Sarcoidosis, and cardiac complications of cancer therapy (sometimes called "CardioOncology"). He serves as Co-Director of the Stanford Amyloid Center, one of the world's leading centers for the care of patients with amyloidosis, and serves as Co-Director of the Stanford Multidisciplinary Sarcoidosis Program. He is an Associate Editor for JACC: CardioOncology, the world's leading journal dedicated to the field of CardioOncology. Dr. Witteles has published extensively in his areas of expertise, and has won many awards for his excellence in both patient care and education.